Chemoinformaics analysis of Tetracosamethyl-cyclododecasiloxane
Molecular Weight | 889.86 | nRot | 0 |
Heavy Atom Molecular Weight | 817.284 | nRig | 24 |
Exact Molecular Weight | 888.226 | nRing | 1 |
Solubility: LogS | -9.397 | nHRing | 1 |
Solubility: LogP | 9.994 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 120 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 48 | No. of Aromatic Carbocycles | 0 |
nHetero | 24 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
nHA | 12 | APOL | 164.073 |
nHD | 0 | BPOL | 278.343 |
QED | 0.217 |
Synth | 4.728 |
Natural Product Likeliness | 0.008 |
NR-PPAR-gamma | 0.006 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.994 |
HIA | 1 |
CACO-2 | -6.695 |
MDCK | 0.00025526 |
BBB | 0 |
PPB | 1.39325 |
VDSS | 5.492 |
FU | 1.66743 |
CYP1A2-inh | 0.088 |
CYP1A2-sub | 0.965 |
CYP2c19-inh | 0.812 |
CYP2c19-sub | 0.984 |
CYP2c9-inh | 0.823 |
CYP2c9-sub | 0.994 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.961 |
CYP3a4-inh | 0.543 |
CYP3a4-sub | 0.027 |
CL | 2.355 |
T12 | 0.029 |
hERG | 0.35 |
Ames | 0.011 |
ROA | 0 |
SkinSen | 0.964 |
Carcinogencity | 0.007 |
EI | 0.996 |
Respiratory | 0.005 |
NR-Aromatase | 0.001 |
Antiviral | Yes |
Prediction | 0.720878 |